WeVote
Log In

Bill

Bill

HRES 685

Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.

119th Congress Introduced by Alma Adams and 8 co-sponsors

HRES 685 advocates for routine antiphospholipid syndrome testing in prenatal care, aiming to improve outcomes for at-risk pregnant individuals through early detection.

Submitted in House
0
WeVote Research Nonpartisan
Bill Summary · HRES 685

Summary of HRES 685: Support for Antiphospholipid Syndrome Testing in Prenatal Screening

Bill Overview

  • Bill Number: HRES 685
  • Title: Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.
  • Status: Submitted in House
  • Introduced On: September 09, 2025
  • Classification: Resolution

Purpose and Intent

HRES 685 aims to advocate for the inclusion of antiphospholipid syndrome (APS) testing as a routine component of prenatal screening. The resolution seeks to raise awareness about APS, a condition that can lead to serious complications during pregnancy, including miscarriage, stillbirth, and other adverse outcomes.

Key Provisions

The resolution includes two main provisions:
1. Support for APS Testing: The House of Representatives expresses its support for making APS testing a standard part of prenatal screening protocols.
2. Call to Action for Medical Associations: The resolution urges professional medical associations and guideline-setting bodies to revise their recommendations to incorporate APS testing into standard prenatal care practices.

Impact

  • Healthcare Providers: The resolution encourages healthcare professionals to adopt APS testing, potentially leading to improved prenatal care and outcomes for pregnant individuals at risk of APS.
  • Pregnant Individuals: Those who may be affected by APS could benefit from early detection and management, reducing the risks associated with the syndrome during pregnancy.
  • Medical Associations: The resolution calls upon these organizations to update their guidelines, which could lead to widespread changes in prenatal care practices across the healthcare system.

Legislative Actions

  • September 09, 2025: The bill was referred to the House Committee on Energy and Commerce for further consideration.
  • September 09, 2025: The bill was submitted in the House.

Sponsors

The resolution is sponsored by:
- Primary Sponsor: Kat Cammack
- Cosponsors:
- Sydney Kamlager-Dove
- Young Kim
- Brittany Pettersen
- Ashley Hinson
- Greg Landsman
- Alma S. Adams
- Sheila Cherfilus-McCormick

Conclusion

HRES 685 represents a significant step towards enhancing prenatal care by advocating for the inclusion of APS testing. By calling for updated guidelines and increased awareness, the resolution aims to improve health outcomes for pregnant individuals and their families.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.